MEDICAL, MILITA
TARY & INDU STRI A L
FEAT
GIVING 5G PATROL ROBOTS THE ADVANTAGE: ADVANTECH’S MIC-770 ASSISTS IN CHINA’S FIGHT AGAINST CORONAVI RUS
A
s a part of its effort to contain the spread of COVID-19,
China is using 5G patrol robots, developed by the Guangzhou Gosuncn Robot Company, which use Advantech technology to monitor mask wearing and body temperatures in public places. The smart city/IoT products and services provider upgraded its 5G-powered police patrol robot with new capabilities to assist first-line police offi conducting disease prevention inspections during this vital time. Because the manual
fficers in
measurement of body temperature exposes public safety personnel to potential health risks, these robots are equipped with fivfi e high-resolution cameras, as well as infrared thermometers capable of scanning the temperature of ten people simultaneously, within a radius of five metres.
If a high temperature, or the
absence of a mask is detected, the robots will send an alert to the relevant authorities. All data can be transmitted to a centralised control centre, which is then followed by a decisive, real-time, situational response.
Moreover, although these
robots are self-driving machines, they can also be controlled remotely, thereby saving
manpower by reducing patrolling responsibilities and preventing cross-infection. It’s no surprise then that these next-generation 5G patrol robots have already been spotted in operation within airports and shopping malls in the cities of Guangzhou, Shanghai, Xi’an, and Guiyang. Due to the high traffi
ffic of
data that has to be processed by these robots, Gosuncn has adopted the industrial
Software for the sick
Q
umulo off ers its cloud-native fi le software, for free, to medical and healthcare research organisations that are working to minimise the spread and impact of the COVID-19 virus. This comes in response to the heavy workload impeding researchers and clinicians in their search for answers to the mysterious infection.
“Research and healthcare organisations across the world are working tirelessly to fi nd
answers and collaborate faster in their COVID- 19 vaccine mission,” said Matt McIlwain, chairman of the board of trustees of the Fred Hutchinson Cancer Research Center, and managing partner of the Madrona Venture Group: “It will be through the work of these professionals globally, sharing and analysing all available data in the cloud, that a cure for COVID-19 will be discovered.” As organisations build tools to track its spread and to develop responsive containment and eradication measures, Qumulo’s cloud software is hoped to prove an asset in enabling actionable results, with cloud-native fi le and data services that will enhance organisations’ powers in capturing,
processing, analysing and sharing data with researchers distributed across geographies. “Using Qumulo’s software to manage and understand petabytes of data in real-time, medical and research organisations around the world can work together and leverage the power of the cloud and hybrid environments to fi ght COVID-19,” said Bill Richter, president and CEO of Qumulo: “This virus requires every organisation to band together and solve this problem with all available technology resources - the smartest minds on the planet collaborating seamlessly.”
Qumulo
www.qumulo.com
edge computer MIC-770 from Advantech, to enable the various technologies it requires to enable its essential functions: artificial intelligence and IoT/ cloud computing. Equipped with an eighth generation Intel Core processor and GPU iModule (MIC-75G20), the MIC-770 is designed to offer a high-level
of performance, necessary to sustain its functions, all while it sits within a ruggedised chassis with cast aluminium heatsink, to protect against vibration, shock, and thermal interference/EMI.
Advantech
www.advantech.com
ATURE
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36
